News
Public · Published
LMAT: Q3 growth and FY guidance remain strong as B. Braun assets expand the vascular portfolio
LeMaitre Vascular reported that third-quarter sales rose 11%, with organic growth of 12%. Adjusted operating income and earnings per share each increased 5%. Its full-year guidance midpoint calls for 11% sales growth and 18% adjusted earnings-per-share growth, while acquired B. Braun assets add products through a staged sales transition.
Published:
Updated:
What happened
LeMaitre Vascular reported that third-quarter sales rose 11%, with organic growth of 12%. Adjusted operating income and earnings per share each increased 5%. Its full-year guidance midpoint calls for 11% sales growth and 18% adjusted earnings-per-share growth, while acquired B. Braun assets add products through a staged sales transition.
Confirmed
Global impact / market context
Sales growth exceeded growth in adjusted operating income and earnings per share, so the reported figures show that stronger revenue has not translated into equally fast profit growth so far. The B. Braun products could add future sales, but their staged transition means the contribution may build over time.
Analyst inference
The guidance midpoint projects faster full-year growth in adjusted earnings per share than in sales, a signal investors may use to judge whether costs and the acquired products support stronger profit per sale. The article provides no share-price reaction or comparison with prior expectations.
Analyst inference
What to watch
- Track whether later quarterly reports show sales growth keeping pace with adjusted operating income and earnings per share, since a widening gap could limit profit growth. Analyst inference
- Watch for updates on the staged transition of B. Braun products, including whether those products begin contributing sales in line with the company’s full-year guidance. Analyst inference
- Compare full-year results with the guidance midpoint of 11% sales growth and 18% adjusted earnings-per-share growth to see whether the outlook is met. Confirmed
Evidence
- Original source link unavailable